APA

Strand V., Michalska M., Birchwood C., Pei J., Tuckwell K., Finch R., Kivitz A. J., Smolen J. S. & Burmester G. R. (2018). Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis. : RMD open.

Chicago

Strand Vibeke, Michalska Margaret, Birchwood Christine, Pei Jinglan, Tuckwell Katie, Finch Rebecca, Kivitz Alan J, Smolen Josef S and Burmester Gerd R. 2018. Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis. : RMD open.

Harvard

Strand V., Michalska M., Birchwood C., Pei J., Tuckwell K., Finch R., Kivitz A. J., Smolen J. S. and Burmester G. R. (2018). Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis. : RMD open.

MLA

Strand Vibeke, Michalska Margaret, Birchwood Christine, Pei Jinglan, Tuckwell Katie, Finch Rebecca, Kivitz Alan J, Smolen Josef S and Burmester Gerd R. Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis. : RMD open. 2018.